On March 14, 2019, Mr. Erez Egozi and the board of directors of Pluristem Therapeutics Inc. mutually agreed that Mr. Egozi will cease to be the Chief Financial Officer, Treasurer and Secretary of the Company, effective as of March 17, 2019. The determination was based on personal reasons and not as a result of any disagreement of Mr. Egozi with the Company. On March 14, 2019, Mrs. Chen Franco-Yehuda, 35, was appointed as the Company's Chief Financial Officer, Treasurer and Secretary, effective as of March 17, 2019.

Prior to her appointment as Chief Financial Officer, Mrs. Franco-Yehuda served as the Company's Head of Accounting and Financial Reporting since July 2016 and, prior to that, the Company's Controller since May 2013. Before joining the Company, from October 2008 to April 2013, Mrs. Franco-Yehuda served as a manager of audit groups relating to public and private companies in various industries at PricewaterhouseCoopers (PwC).